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ABSTRACT
Objectives: To estimate the prevalence and pattern of
multimorbidity in the Indonesian adult population.
Design: Cross-sectional study.
Setting: Community-based survey. The sampling
frame was based on households in 13 of the 27
Indonesian provinces, representing about 83% of the
Indonesian population.
Participants: 9438 Indonesian adults aged 40 years
and above.
Main outcome measures: Prevalence and pattern of
multimorbidity by age, gender and socioeconomic
status.
Results: The mean number of morbidities in the
sample was 1.27 (SE±0.01). The overall age and sex
standardised prevalence of multimorbidity was 35.7%
(34.8% to 36.7%), with women having significantly
higher prevalence of multimorbidity than men (41.5%
vs 29.5%; p<0.001). Of those with multimorbidity,
64.6% (62.8% to 66.3%) were aged less than
60 years. Prevalence of multimorbidity was positively
associated with age (p for trend <0.001) and affluence
(p for trend <0.001) and significantly greater in women
at all ages compared with men. For each 5-year
increment in age there was an approximate 20%
greater risk of multimorbidity in both sexes (18% in
women 95% CI 1.14 to 1.22 and 22% in men 95% CI
1.18 to 1.26). Increasing age, female gender, non-
Javanese ethnicity, and high per-capital expenditure
were all significantly associated with higher odds of
multimorbidity. The combination of hypertension with
cardiac diseases, hypercholesterolemia, arthritis, and
uric acid/gout were the most commonly occurring
disease pairs in both sexes.
Conclusions: More than one-third of the Indonesian
adult population are living with multimorbidity with
women and the more wealthy being particularly
affected. Of especial concern was the high prevalence
of multimorbidity among younger individuals.
Hypertension was the most frequently occurring
condition common to most individuals with
multimorbidity.
INTRODUCTION
Multimorbidity, the simultaneous existence
of two or more chronic health conditions
within an individual, without a defining
primary index disease, is increasingly becom-
ing the norm rather than the exception, par-
ticularly in high-income countries.1–3 It
increases progressively with age,2 4 and is
associated with increased risk of premature
mortality and reduced quality of life.5 In add-
ition to these significant individual-level
issues, multimorbidity is associated with sub-
stantial societal costs due to increased health-
care utilisation, and the greater demands on
the healthcare system that it creates.6–10
Furthermore, the pharmacomanagement of
multimorbidity is multifaceted, often requir-
ing polypharmacy that in turn is associated
with high rates of adverse complications.8 11
Moreover, its clinical management is
complex and in practice, hindered by the
lack of specific guidelines for the manage-
ment of patients with multiple chronic
conditions.12
Previously, the study of the burden of mul-
timorbidity has largely been confined to
developed countries due to the availability of
relevant data with which to examine this
issue.13 However, there is increasing recogni-
tion that the burden of multimorbidity is
of increasing importance to populations
in lower and middle-income countries.
Strengths and limitations of this study
▪ This is the first study to examine the prevalence,
pattern and socioeconomic correlates of multi-
morbidity among Indonesian adults using data
from a large representative cross-sectional
survey.
▪ In addition to informing on prevalence of mor-
bidity we examined the age and gender patterns
associated with the most frequently occurring
combinations of chronic morbid conditions.
▪ Limitations of the study are the use of self-
reported data and the restriction to a predefined
set of morbidities.
▪ The cross-sectional nature of the study pre-
cluded any causal inference from being made.
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Historically, the pattern of mortality in these countries
has largely been dominated by communicable diseases;
but, substantive successes in public health over the past
several decades in these countries has led not only to
marked gains in life expectancy but an increase in the
prevalence of chronic conditions placing additional
strain on healthcare systems that are ill-equipped for
coping with the growing widespread demand for
chronic disease care.13–17
Indonesia, the world’s fourth most populous nation, is
in the midst of a profound demographic and epidemio-
logical transition.18 Recent studies have identified
Indonesia’s sizeable chronic disease burden but little is
known regarding the pattern of multimorbidity in the
population.19 Although Indonesia has an extensive
primary healthcare structure that is largely delivered
through a network of community health centres
(Puskesmas), auxiliary health centres (Pustu) and private
medical practice, recent evidence suggests that the
country has limited capacity in its public health system
to cope with any further increases in healthcare
demand.20 The purpose of the current study is therefore
to inform on the prevalence, patterns and risk factors
associated with multimorbidity in the Indonesian popu-
lation; such information is a vital pre-requisite for the
design and implementation of an effective primary
healthcare system that is capable of delivering a compre-
hensive continuum of care to patients with multiple
morbidities.
METHODS
Data source
Data for this study are from the fourth wave of
Indonesian Family Life Survey (IFLS-4). IFLS is an
ongoing health and socioeconomic comprehensive lon-
gitudinal survey consisting of four waves, beginning in
1993 and collected information on individual, house-
hold and community level. The original sampling frame
was based on households in 13 of the 27 Indonesian
provinces, representing about 83% of the Indonesian
population in 1993.21 Briefly, IFLS-1 collected informa-
tion from over 22 000 individuals living in 7224 house-
holds. These original households and their split-offs
were followed in subsequent waves fielded in 1997/1998,
2000 and 2007/2008. The recontact rates for the target
households were more than 90% in all follow-up surveys.
Moreover, in IFLS-4, 90.6% of target households were
successfully recontacted with the lowest recontact rate in
Jakarta (80.3%). The fourth wave of the survey included
44 103 (51.0% female) individuals from 13 535 house-
holds from urban and rural locations.21 The sampling
and survey methods for the IFLS have been discussed in
detail elsewhere.21 The IFLS-4 data are open for public
use after registration on their website (http://www.rand.
org/labor/FLS/IFLS/ifls4.html). IFLS-4 collected
individual-level data on anthropometry, morbidity indi-
cators, healthcare utilisation, health behaviours and
household expenditure as well as information on ques-
tions related to chronic morbid conditions in partici-
pants aged 40 years and above. Hence, this analysis is
limited to that age-group.
Measurements
For our analysis, multimorbidity was the primary
outcome measure and was defined as the presence of
two or more chronic conditions in individual respon-
dents.1 2 7 8 The individual morbidity status was ascer-
tained either through active measurements, or through
self-report or both. Active measurements were obtained
by a qualified team of trained nurses for biophysical
parameters namely anthropometry, blood pressure (BP)
and total cholesterol levels.21 Three BP measurements
were obtained using Omron self-inflating sphygmoman-
ometers with a digital read-out and total cholesterol was
measured using Cardiochek PA system.21 To determine
the occurrence of self-reported chronic conditions
respondents were asked the question “Has a doctor/
paramedic/nurse/midwife ever told you that you had
following chronic conditions of diseases?” with response
options: hypertension, diabetes, tuberculosis, asthma and
other chronic lung diseases, cardiac diseases(heart
attack/coronary heart disease/angina or other heart dis-
eases), liver diseases, stroke, cancer or malignancies,
arthritis/rheumatism, uric acid/gout, depression, vision
and hearing abnormalities. Among respondents with no
reported diabetes or heart problems, undiagnosed dia-
betes and heart problems were identified based on the
number of affirmative responses to conditions symptom-
atic of the respective disease.22 For diabetes, these were:
(1) often wake up to urinate during the night, (2) a cut
or wound takes a long time to heal and (3) often have
headache when waking up in the morning. For heart
problems, these were (1) ever felt pain on the left side
of your chest, (2) ever felt chest pains when climbing
upstairs or uphill, and (3) ever felt chest pains when
being active or walking fast. Undiagnosed diabetes was
defined as having all three symptoms; undiagnosed
heart problem was defined as having at least two symp-
toms. Beside self-reported depression, presence of
depression was quantitatively measured using a short
version of the Centre for Epidemiologic Studies
Depression Scale (CES-D); a series of 10 questions exam-
ining depression symptoms. In this study, the CES-D
score was treated as a dichotomous categorical variable
with a score of equal to or greater than 11 representing
significant depressive symptoms.23 Participants with a
positive history of asthma and other chronic lung dis-
eases were defined as having a chronic respiratory
disease, while arthritis and rheumatism were grouped
together as arthritis.
For this analysis, we included obesity (body mass index
(BMI) ≥30 kg/m2) and hypercholesterolemia (blood
total cholesterol value >6.2 mmol/L as additional
chronic morbidities based on anthropometric and bio-
chemical measurements. Hypertensive status was
2 Hussain MA, et al. BMJ Open 2015;5:e009810. doi:10.1136/bmjopen-2015-009810
Open Access
group.bmj.com on December 9, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
ascertained based on self-report and the mean BP value
of three measurements. Respondents were classified as
hypertensive if they had a mean systolic BP ≥140 mm Hg
and/or mean diastolic BP ≥90 mm Hg, or were cur-
rently taking hypertension medication.24
Sociodemographic factors as individual level determi-
nants were based on self-report and included age,
gender, ethnicity ( Javanese, non-Javanese), household
location (urban, rural), marital status(currently married,
currently not married including unmarried, separated
or divorced and widow(er)), education level (elementary
education or less, high school completed, graduate and
above), participants economic status (per capita expend-
iture for consumption). Per capita expenditure, the
measure of current or ‘immediate’ living standard
rather than income, was considered as economic status
due to the fact that expenditure is the preferred direct
measure of welfare in developing countries.25–28
Monthly household expenditure for consumption
include the following food items (rice, meat and fish,
vegetables, cooking oil, granulated sugar), and non-food
items (kerosene). For all of the analyses, per capita
expenditure was entered as a log-transformed continu-
ous variable to make the distribution more symmetrical
and to reduce the effect of any outliers. Per-capita
monthly expenditure was categorised to quintiles: q1
(lowest) to q5 (highest).
Statistical analysis
As the prevalence of multimorbidity varied substantially
with age and sex,1 we analysed the data stratified by age
group (40–59 years and ≥60 years) and separately for
men and women. Chronic conditions with prevalence
estimates ≥1% were included in estimating multimorbid-
ity prevalence across age groups and sex. The prevalence
of multimorbidity was estimated in relation to all socio-
demographic correlates. All prevalence measures were
direct-standardised to the 2010 age and sex distribution
of the Indonesia population (2010 Indonesian
Census).29 We applied non-parametric tests to test the
differences in the mean number of morbidities across
different sociodemographic covariates.
The most common clusters of chronic conditions were
assessed by clustering the disease types per individual,
then reporting the most common (frequencies) within
dyads and triads, and also by estimating the prevalence
of each cluster within the study population (per 100
persons). Data were reported only for the top 10 fre-
quently occurring combinations of chronic conditions in
the sample. Ratios between observed versus expected
(multimorbidity coefficients) were also calculated and
are reported.30 We used the χ2 to test whether the
observed prevalence of comorbidity dyad and triad were
greater than would be expected if the diseases occurred
independently.31 Binary logistic regression was used to
determine socioeconomic and demographic predictors
of multimorbidity compared to zero or one morbid con-
dition. Results are presented in terms of the adjusted
OR (AOR) with 95% CIs. Multicollinearity for covariates
was tested using the variance inflation factor and toler-
ance values, which were negative. Marginal statistics were
computed to estimate the linear prediction of mean
number of morbidities and probabilities of multimorbid-
ity across age and sex categories. All analyses were per-
formed using the inverse probability sampling weights.21
For analysis involving complete cases only we used
inverse probability weighted method and complete cases
were weighted by the inverse of their probability of
being a complete case.32 Data were analysed using Stata
software V.12.0 for Windows (StataCorp LP, College
Station, Texas, USA) and p values of less than 0.05 were
considered statistically significant.
RESULTS
Participant’s characteristics
Of 11 712 participants aged 40 years or above inter-
viewed in the survey, 2014 (17.5%) did not have com-
plete information related to all chronic diseases and
thus they were excluded from further analysis (figure 1).
We analysed data from 9438 (51.6% women) respon-
dents for whom complete information on all included
chronic diseases were available. The respondents with
complete information were on average 3 years younger
than those with incomplete information (54.1 years vs
57.2 years; p<0.001). Participants with complete informa-
tion were more likely to be female (AOR: 1.2; 95% CI
1.1 to 1.4), currently married (AOR: 1.3; 1.1 to 1.5),
high school or above educated (AOR: 1.3; 1.2 to 1.5),
from a rural area (AOR: 1.1; 1.0 to 1.2), and of Javanese
ethnicity (AOR: 1.1; 1.0 to 1.3). However, respondents
with complete information did not differ significantly
from those with incomplete information in terms of per
capita expenditure. Of those included in the analysis,
more than half (53.5%) were of Javanese ethnicity,
57.8% were from rural areas, and 72% of respondents
had attained an elementary level of education or less.
Men and women did not differ significantly across
different sociodemographic characteristics except for
education and marital status (see online supplementary
table S1).
Prevalence of chronic conditions and multimorbidity
Hypertension, hypercholesterolaemia, cardiac diseases
and arthritis were the most prevalent chronic morbid-
ities affecting 10%–48% of the population. The distribu-
tion of these conditions varied across age and sex group
(table 1). The overall prevalence of hypertension, hyper-
cholesterolemia, cardiac diseases and arthritis in women
were 52%, 20%, 14% and 12%, respectively, compared
to 44%, 12%, 12.7% and 7.8%, in men. The majority of
the chronic morbidities were significantly higher in the
older (≥60 years) versus younger (40–59 years) indivi-
duals (p<0.05).
The mean number of morbidities in the sample was
1.27 (SE±0.01) and again varied by age and sex
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(table 2). Women had significantly higher number of
morbidities compared to men (1.50 vs 1.15; p<0.001)).
The overall age and sex standardised prevalence of mul-
timorbidity was 35.7% (95% CI 34.8% to 36.7%) with
women having significantly higher prevalence of multi-
morbidity than men both overall (41.5% v 29.5%;
p<0.001) and at all ages (figure 2 and table 2). Of the
people with at least one morbidity, 48.8% (47.5% to
50.1%) had multimorbidity. The number of morbidities
and the proportion of people with multimorbidity
showed a linear trend with increasing age (see online
supplementary figure S1); each 5-year increment in age
was associated with approximately 20% greater risk of
multimorbidity in men and women. The mean number
Table 1 Age-adjusted weighted prevalence of chronic conditions among Indonesian aged more than 40 years based on
IFLS4 survey
Age adjusted prevalence
(40–59 years)
Age adjusted prevalence
(>60 years)
Percentage (95% CI) Percentage (95% CI)
Diseases Men Women Men Women
Hypertension 37.9 (36.1 to 39.7) 45.8 (44.0 to 47.5) 58.8 (55.8 to 61.8) 69.8 (67.2 to 72.5)
Hypercholesterolaemia 12.4 (11.2 to 13.7) 18.4 (17.1 to 19.8) 10.5 (8.6 to 12.3) 23.6 (21.2 to 26.1)
Cardiac diseases 11.1 (9.9 to 12.2) 13.4 (12.2 to 14.6) 17.1 (14.8 to 19.4) 17.8 (15.6 to 19.9)
Obesity (BMI ≥30) 5.0 (4.2 to 5.8) 11.3 (10.2 to 12.4) 1.5 (0.8 to 2.3) 4.4 (3.3 to 5.4)
Arthritis 6.0 (5.2 to 6.9) 10.2 (0.9 to 11.2) 12.2 (10.2 to 14.1) 16.6 (14.5 to 18.6)
Vision abnormality 6.7 (5.8 to 7.6) 6.5 (5.7 to 7.3) 9.8 (8.1 to 11.5) 10.5 (8.9 to 12.2)
Uric acid/gout 4.6 (3.9 to 5.4) 7.2 (6.3 to 8.0) 6.3 (4.9 to 7.7) 8.4 (6.8 to 10.0)
Depression 4.3 (3.6 to 5.0) 6.7 (5.8 to 7.5) 4.4 (3.2 to 5.6) 8.4 (6.8 to 9.9)
Chronic respiratory diseases 4.1 (3.4 to 4.8) 3.4 (2.7 to 4.0) 9.5 (7.7 to 11.2) 4.3 (3.2 to 5.5)
Diabetes mellitus 3.8 (3.0 to 4.4) 4.2 (3.5 to 4.8) 5.2 (3.9 to 6.5) 4.4 (3.3 to 5.5)
Hearing problem 0.7 (0.4 to 1.0) 0.6 (0.3 to 0.8) 2.0 (1.2 to 2.8) 2.6 (1.7 to 3.5)
Stroke 0.3 (0.1 to 0.5) 1.0 (0.6 to 1.3) 2.1 (1.2 to 2.9) 1.1 (0.5 to 1.7)
Liver diseases 0.9 (0.6 to 1.3) 0.7 (0.4 to 0.9) 0.7 (0.2 to 1.3) 0.1 (0.0 to 0.2)
Tuberculosis 0.6 (0.3 to 0.8) 0.3 (0.1 to 0.5) 0.6 (0.2 to 1.0) 0.3 (0.0 to 0.5)
Cancer 0.1 (0.0 to 0.3) 0.7 (0.4 to 1.0) 0.2 (0.0 to 0.4) 0.7 (0.2 to 1.3)
BMI, body mass index; IFLS-4, Indonesian Family Life Survey.
Figure 1 IFLS 4 participants
and selection of study sample
from the original sampled
population. CES-D, Centre for
Epidemiologic Studies
Depression Scale; IFLS-4,
Indonesian Family Life Survey.
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of chronic conditions was significantly higher in people
of non-Javanese ethnicity (1.37 vs 1.27; p=<0.001) com-
pared with Javanese ethnicity, who lived in urban com-
pared with rural areas (1.48 vs 1.17; p<0.001), who had
the highest per capita expenditure versus the lowest
(p<0.001), and with educational attainment (p for trend
<0.001).
Table 3 shows the results of multivariable multinomial
logistic regression of factors associated with multimorbid-
ity. Increasing age, female gender, non-Javanese ethnicity
and high per-capital expenditure were all significantly
associated with higher odds of multimorbidity. Higher
education status was significantly correlated with higher
odds of multimorbidity but only in men. Women
younger than 70 years of age had significantly higher
odds of multimorbidity relative to men (figure 3).
Common multimorbidity combinations
Figure 4 presents the leading five most frequently occur-
ring morbidity dyads and triads among respondents with
multimorbidity. The details of observed and expected
prevalence rates for these combinations and multimor-
bidity coefficients (observed/expected ratio) are pre-
sented in the appendix (see online supplementary
tables S2–S5). Most of the disease combinations were
identified as the most prevalent conditions in table 1.
The combination of hypertension with cardiac diseases,
hypercholesterolaemia, arthritis and uric acid/gout were
the most commonly occurring dyads in both sexes. The
majority of these combinations showed statistically sig-
nificantly higher observed prevalence than would be
expected at random. The most prevalent individual
disease conditions such as hypertension, hypercholester-
olaemia, prevalent cardiac diseases and arthritis domi-
nated the most frequent triad combinations. These four
conditions, together with diabetes mellitus, uric acid/
gout, chronic respiratory diseases, obesity and vision
abnormalities, were the main components of the 10
most prevalent triads across age groups with minimal dif-
ferences between the sexes.
DISCUSSION
This study is the first to report on the population preva-
lence of multimorbidity in the Indonesian adult
population using subnational data from the Indonesia
Family Life Survey (IFLS-4). More than a third of adults
over 40 years of age and half of individuals above
60 years had multimorbidity, but the pattern varied
markedly across different sociodemographic character-
istics. Increasing age, female gender, high per-capita
household expenditure and urban locality were signifi-
cant predictors of multimorbidity status.
In the current study, the prevalence of hypertension
as well as self-reported cardiac diseases and diabetes was
comparable with previous estimates that have been
reported using nationally representative data.33–37 The
prevalence of obesity was, however, lower than in earlier
reports although this is likely to be due in part to the
lower cut-point for BMI used to define obesity in those
studies.37 With respect to the prevalence of other major
chronic conditions including hypertension, hypercholes-
terolaemia and diabetes our findings are comparable
with age and sex specific prevalence estimates reported
in geographically and economically similar Asian coun-
tries such as Malaysia, Thailand and the Philippines.38
Our findings demonstrate that the most commonly
occurring comorbidities, were hypertension, prevalent
cardiac diseases, arthritis, and hypercholesterolaemia
together with vision abnormality and obesity. Similar
combinations of prevalent cardiometabolic morbidities
have also been reported by the recent
systematic-reviews.39 Stratifying the population by age
and sex did not materially alter our results, although
some interesting patterns were noted. For example, the
most frequently occurring dyad (which comprised hyper-
tension and hypercholesterolaemia) occurred with a fre-
quency of 11% indicating that there is no dominant
combination of morbid conditions that affects the popu-
lation. From a public health perspective, this is challen-
ging and requires development of comprehensive and
contextualised clinical practice guidelines offering clin-
ical management and treatment decision support for
patients with multiple chronic diseases.40
It is difficult to directly compare our findings with
those from previous studies due to differences in study
methodology including in how multimorbidity was
defined7 31 However, systematic reviews of studies have
indicated a prevalence rate of multimorbidity ranging
from less than 5% to more than 90%, with notable
Figure 2 The proportion of
population with number of chronic
condition or morbidities according
to age groups and gender.
Hussain MA, et al. BMJ Open 2015;5:e009810. doi:10.1136/bmjopen-2015-009810 5
Open Access
group.bmj.com on December 9, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
Table 2 Age-adjusted mean number of chronic condition (SE) and prevalence of multimorbidity across different sociodemographic covariates (N=9438)
40–60 years More than 60 years
Men Women Men Women
Sociodemographic
characteristics
Weighted
% of
sample
Mean
number of
morbidities
(SE)
Prevalence %
(95% CI)
Mean
number of
morbidities
(SE)
Prevalence %
(95% CI)
Mean
number of
morbidities
(SE)
Prevalence %
(95% CI)
Mean
number of
morbidities
(SE)
Prevalence %
(95% CI)
Location
Rural 57.8 0.8 (0.02) 21.0 (18.9 to 23.1) 1.2 (0.02) 30.8 (28.5 to 33.1) 1.3 (0.04) 33.7 (29.9 to 37.5) 1.6 (0.05) 43.9 (40.0 to 47.8)
Urban 42.2 1.1 (0.02) 29.1 (26.7 to 31.5) 1.5 (0.03) 41.1 (38.7 to 43.5) 1.7 (0.06) 47.4 (43.0 to 51.9) 2.0 (0.06) 58.3 (54.3 to 62.3)
Ethnicity
Javanese 53.5 0.9 (0.02) 21.9 (19.7 to 24.0) 1.3 (0.02) 33.5 (31.1 to 35.9) 1.3 (0.05) 0.3 (30.7 to 38.9) 1.7 (0.05) 48.2 (44.1 to 52.3)
Non-Javanese 46.5 1.0 (0.02) 27.7 (25.4 to 30.0) 1.4 (0.30) 37.6 (35.2 to 40.0) 1.5 (0.05) 43.3 (39.1 to 47.4) 1.7 (0.05) 50.8 (46.7 to 54.8)
Education
Elementary
education or less
71.6 0.9 (0.02) 20.7 (18.7 to 22.7) 1.3 (0.02) 33.7 (31.7 to 35.6) 1.3 (0.04) 35.0 (31.8 to 38.3) 1.7 (0.04) 48.0 (45.0 to 51.1)
High school 22.2 1.1 (0.03) 28.3 (25.3 to 31.2) 1.5 (0.04) 41.1 (37.8 to 44.7) 1.7 (0.08) 51.8 (44.9 to 58.7) 2.2 (0.15) 62.4 (53.3 to 71.6)
Graduate and
above
6.1 1.3 (0.07) 35.9 (30.3 to 41.5) 1.6 (0.08) 47.6 (40.8 to 54.5) 2.0 (0.21) 58.7 (44.5 to 72.9) 3.0 (0.52) 76.8 (63.6 to 90.0)
Marital status
Currently married 81.0 1.0 (0.02) 24.6 (23.0 to 26.2) 1.3 (0.02) 34.9 (33.0 to 36.8) 1.4 (0.03) 37.9 (34.8 to 41.0) 1.7 (0.07) 46.6 (41.6 to 51.6)
Currently not
married
19.0 0.9 (0.07) 23.0 (16.2 to 29.9) 1.3 (0.04) 36.4 (32.5 to 40.3) 1.8 (0.12) 45.0 (36.0 to 54.0) 1.8 (0.04) 51.0 (47.3 to 54.8)
Per capita expenditure
Q1 (lowest) 22.9 0.7 (0.03) 15.5 (12.4 to 18.5) 1.0 (0.04) 28.3 (24.7 to 31.9) 1.2 (0.06) 29.9 (24.3 to 35.5) 1.5 (0.07) 41.2 (35.3 to 47.0)
Q2 21.0 0.9 (0.04) 23.3 (19.8 to 26.9) 1.2 (0.04) 29.7 (26.0 to 33.3) 1.2 (0.07) 31.7 (25.8 to 37.7) 1.7 (0.08) 47.7 (41.3 to 54.2)
Q3 20.6 1.0 (0.04) 24.7 (21.2 to 28.1) 1.3 (0.04) 35.1 (31.4 to 38.7) 1.4 (0.08) 37.1 (30.9 to 43.4) 1.7 (0.08) 50.0 (43.5 to 56.4)
Q4 19.7 1.0 (0.04) 26.0 (22.3 to 29.6) 1.4 (0.05) 39.1 (35.5 to 42.8) 1.6 (0.08) 47.3 (40.2 to 54.4) 1.8 (0.08) 51.7 (45.2 to 58.2)
Q5 (highest) 15.6 1.3 (0.05) 34.0 (29.9 to 38.1) 1.6 (0.05) 46.6 (42.6 to 50.7) 1.8 (0.09) 58.7 (50.9 to 66.6) 2.2 (0.11) 61.2 (54.1 to 68.4)
Overall* 1.0 (0.01) 24.6 (23.0 to 26.1) 1.3 (0.02) 35.4 (33.8 to 37.1) 1.4 (0.03) 38.7 (35.8 to 41.7) 1.7 (0.04) 49.4 (46.5 to 52.3)
*Overall difference between men and women were significant at P value <0.001.
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differences across different age groups and study set-
tings.7 41 A recent study analysing data from six lower-
income and middle-income countries also reported
the multimorbidity prevalence to range from about
4–34%.42 In line with earlier studies, we observed the
prevalence of multimorbidity to increase with age and
was higher among those living in urban areas.1 7 14 42–44
However, due to the age distribution of the population
the absolute burden of multimorbidity was greater
among those under 60 years of age in whom two-thirds
had the condition, consistent with previous observations
that multimorbidity represents a significant health chal-
lenge to younger as well as older populations.45
In agreement with previous studies,1 2 16 42 43 we
observed women to be more vulnerable to multimorbid-
ity compared to men. And as in other lower-income and
middle-income countries undergoing an epidemio-
logical transition,46 the prevalence of multimorbidity
increased with greater affluence which is in contrast to
the situation in higher-income countries where the least
economically advantaged are typically at greatest risk of
multimorbidity.1 14 15 42 It is possible, however, that this
discrepancy may be explained by respondents from
lower socioeconomic background being less likely to
report their health condition either due to limited
access to healthcare or under diagnosis.47 We also
observed people of Javanese ethnicity to have a lower
prevalence of multimorbidity compared to other ethnici-
ties which may reflect differences in socioeconomic
position.
A major strength of this study was the large randomly
selected representative sample of Indonesian population
which allows for greater generalisation of results.
Population-based prevalence estimates of multimorbidity
are essential for understanding the true health status of
the community. However, there are some significant
study limitations. The cross-sectional nature of the study
did not permit any causal inferences to be made. We
may have underestimated the prevalence of multimor-
bidity, since only 15 chronic conditions were included in
Table 3 Multivariable analysis of the association between
sociodemographic characteristics and multimorbidity in
Indonesian population
Adjusted OR (95% CI)
Sociodemographic
characteristics Men Women
Age (years)
40–49 1.0 1.0
50–59 1.6 (1.3 to 1.9) 1.7 (1.5 to 2.0)
60–69 2.3 (1.8 to 2.8) 2.4 (2.0 to 2.9)
70+ 3.6 (2.8 to 4.6) 2.3 (1.7 to 2.9)
Housing location
Rural 1.0 1.0
Urban 1.3 (1.1 to 1.5) 1.4 (1.3 to 1.6)
Ethnicity
Javanese 1.0 1.00
Non-Javanese 1.4 (1.1 to 1.5) 1.1 (1.1 to 1.3)
Education
Elementary education
or less
1.0 1.0
High school 1.2 (1.0 to 1.5) 1.0 (0.9 to 1.2)
Graduate and above 1.5 (1.1 to 1.9) 1.2 (0.9 to 1.5)
Marital status
Currently married 1.0 1.0
Currently not married 1.1 (0.8 to 1.4) 1.1 (0.9 to 1.2)
Per capita expenditure quintiles
Q1 (lowest) 1.00 1.0
Q2 1.3 (1.1 to 1.7) 1.1 (0.9 to 1.3)
Q3 1.5 (1.2 to 1.9) 1.3 (1.1 to 1.6)
Q4 1.7 (1.3 to 2.1) 1.5 (1.2 to 1.8)
Q5 (highest) 2.2 (1.6 to 2.9) 1.8 (1.5 to 2.3)
Figure 3 Marginal plots showing
relative OR for each category of
age and sex compared to
40–44 years male participants,
adjusted for other
socio-demographic variables.
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the survey and the outcome was based on self-report,
which may have introduced some misclassification bias.
Nevertheless, this type of misclassification is likely to
have been at random. We performed a complete case
analysis which has the potential to introduce attrition
bias if the excluded individuals are systematically differ-
ent from those included. However, we used inverse prob-
ability weighted method to directly analyse only the
complete cases with special weights assigned to those
cases based on estimated probabilities of completeness,
thereby minimising the possibility of attrition bias.32 48
Moreover, the proportion of missing data was small and
the prevalence of individual diseases did not vary signifi-
cantly across participants with complete and incomplete
information. The measure of multimorbidity was only
concerned with the number of diseases and did not take
into consideration the intensity or severity of disease nor
did it take into account any undiagnosed chronic
ailment. Moreover, the present study included obesity as
a chronic condition, which has been previously been
considered to be only a risk factor for multimorbidity,
rather than a disease entity.49–51 However, recent system-
atic reviews have shown obesity to be an independent
predictor of patterns of multimorbidity, thereby creating
an evidence-base for obesity to be included as a morbid
condition.13 52 Lastly, we used observed-to-expected
ratios to analyse multimorbidity pattern, which apart
from the technical difficulties implicit to the extraordin-
ary numbers of theoretically possible combinations of
diseases, depend on the prevalence of the individual dis-
eases and do not adequately adjust for chance multimor-
bidity when non-random multimorbidity exists.39
In summary, multimorbidity affects more than
one-third of the Indonesian adult population with a
greater absolute burden occurring in younger indivi-
duals and in women. Hypertension was almost integral
to all patterns of multimorbidity at all ages indicating
that effective interventions to reduce mean population
BP should be given high priority in the Indonesian
population. The recent comprehensive review on health
system issues on managing non-communicable diseases
(NCD) in the Asia-Pacific region highlighted a shortage
of adequately trained health workers to manage NCDs; a
lack of investment in training in the management of
chronic diseases; weak health information systems that
lack integrated and coordinated collection of data on
chronic diseases; and unsuitable service delivery models
for the continuum of care required for chronic
diseases.53
A comprehensive generalist care approach that is
mainly, but not exclusive to primary care, has been sug-
gested to be the most suitable strategy for the manage-
ment of patients with multimorbidity.1 44 However, the
delivery of primary healthcare in Indonesia is principally
built around the management of single diseases and
therefore a greater focus on the development of contex-
tualised treatment protocols for the management of
comorbid conditions is needed. Indonesia has adopted
the WHO Package of essential non-communicable disease
interventions (WHO PEN) for primary healthcare in low-
resource settings.54 However, it is still at an early stage of
implementation and requires scaling-up at the national
level. Given the paucity of data on the predictors and
patterns of multimorbidity in low and middle income
countries,13 41 findings from the current study are timely
and provide novel insights into the burden of multimor-
bidity in these countries. However, further research is
needed to understand how multimorbidity impacts
healthcare utilisation and healthcare costs particularly in
these low-resource settings.
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